Compounds > furosemide

furosemide and losartan potassium

furosemide has been researched along with losartan potassium in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Derzsiová, K; Mydlík, M; Zemberová, E1
Benöhr, P; Freudenthaler, S; Gleiter, CH; Grenz, A; Mörike, K; Osswald, H; Schmidt, T; Selzer, T1
Charles, J; Miller, G; Ng, A1
Abaterusso, C; Boaretti, C; De Biase, V; Gambaro, G; Loschiavo, C; Lupo, A; Pertica, N; Tobaldini, O; Trabucco, G1

Trials

1 trial(s) available for furosemide and losartan potassium

ArticleYear
Do alterations of endogenous angiotensin II levels regulate erythropoietin production in humans?
    British journal of clinical pharmacology, 2003, Volume: 56, Issue:4

    Topics: Adult; Angiotensin II; Cross-Over Studies; Diet, Sodium-Restricted; Diuretics; Erythropoietin; Furosemide; Glomerular Filtration Rate; Humans; Infusions, Intravenous; Male; Renin-Angiotensin System; Sodium Chloride

2003

Other Studies

4 other study(ies) available for furosemide and losartan potassium

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Metabolism of vitamin B6 and its requirement in chronic renal failure.
    Kidney international. Supplement, 1997, Volume: 62

    Topics: Adult; Diuretics; Erythropoietin; Furosemide; Humans; Immunity, Cellular; Injections, Intravenous; Kidney Failure, Chronic; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Pyridoxal Phosphate; Pyridoxine; Reference Values; Vitamin B 6 Deficiency

1997
Management of renal problems in Australian general practice.
    Australian family physician, 2005, Volume: 34, Issue:11

    Topics: Adult; Age Distribution; Aged; Antacids; Australia; Calcium Carbonate; Diuretics; Erythropoietin; Family Practice; Female; Furosemide; Humans; Kidney; Kidney Diseases; Male; Middle Aged; Referral and Consultation; Sex Distribution; Ultrasonography

2005
Prolonged conservative treatment for frail elderly patients with end-stage renal disease: the Verona experience.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2008, Volume: 23, Issue:4

    Topics: Aged; Aged, 80 and over; Diuretics; Erythropoietin; Female; Follow-Up Studies; Frail Elderly; Furosemide; Glomerular Filtration Rate; Guideline Adherence; Humans; Italy; Kidney Failure, Chronic; Length of Stay; Male; Morbidity; Quality of Life; Renal Dialysis; Retrospective Studies; Survival Rate; Time Factors; Treatment Outcome

2008